HOME >> BIOLOGY >> NEWS
Antibody extends life of mice with breast cancer

BUFFALO, N.Y. -- A monoclonal antibody developed by researchers at the University at Buffalo has been shown to extend significantly the survival of mice with human breast-cancer tumors and to inhibit the cancer's spread to the lungs in the animals by more than 50 percent.

The antibody, named JAA-F11, targets a particular disaccharide, an antigen known as TF-Ag, which aids the adhesion and spread of certain cancer cells. While the antibody did not kill the cancer cells, it blocked stages of cancer-cell growth that allow the cells to adhere to organ tissue, the research showed.

Results of the research appeared in the November 2006 issue of the journal Neoplasia.

Mice with breast-cancer tumors that received the antibody had a median survival time of 72 days, compared to 57 days for the animals that did not receive JAA-F11, the study found. In addition, exposing cultures of tumor cells to the antibody inhibited cell growth by a statistically significant 16 percent.

Kate Rittenhouse-Olson, Ph.D., associate professor of clinical and laboratory sciences in the UB School of Medicine and Biomedical Sciences, is senior author on the study.

"This antibody binds with a carbohydrate on the tumor cell surface that is involved in adhesion of the cell during the metastatic process," said Rittenhouse-Olson. "Not only would drugs attached to the antibody JAA-F11 bind to the tumor cell surface to direct their cytotoxic effect, but the binding of the antibody itself would block the cell from metastasizing."

The antibody was tested using in vitro models of tumor cell growth, in assays to determine its ability to damage or kill cells (cytotoxicity), in various models of cancer metastasis, and, finally, in mice with metastatic breast cancer.

"In addition to providing a survival advantage," said Rittenhouse-Olson, "JAA-F11 immunotherapy reduced the metastatic tumor burden significantly, reflected by both a dramatic decline in the overall in
'"/>

Contact: Lois Baker
ljbaker@buffalo.edu
716-645-5000 x1417
University at Buffalo
11-Dec-2006


Page: 1 2

Related biology news :

1. Antibody-altering protein found in developing B cells
2. Antibody retards growth and induces death in liver cancer cells
3. Antibody linked to MS significantly higher in spinal fluid of blacks
4. Antibody-based therapies effective at controlling malaria
5. Antibody therapy prevents type 1 diabetes in mice
6. Antibody to a naturally-occurring sugar chain in colon inhibits inflammatory bowel disease
7. Antibody that neutralizes most HIV strains described by scientists at The Scripps Research Institute
8. Back to the future: Mastodon extends the time limit on DNA sequencing
9. Wiley extends publishing partnership with the American Institute of Chemical Engineers
10. Nexavar significantly extends overall survival by 44 percent in liver cancer patients
11. Vitamin extends life in yeast, Dartmouth Medical School researchers find

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... YORK (PRWEB) , ... September 03, 2020 , ... ... real world data, today announced that an extensive third-party assessment of the company’s ... and compliant when measured against federal security regulations. The comprehensive evaluation reviewed Litmus’ ...
(Date:8/23/2020)... ... August 21, 2020 , ... The August edition of ... now available on the company’s global website. Crystallography Times—an electronic newsletter published by ... news and crystallographic research. , The latest issue of Crystallography Times introduces ...
(Date:8/12/2020)... ... August 11, 2020 , ... Both Roche, ... have entered into license agreements with Housey Pharma’s HMI subsidiary to gain access ... J&J have annual Research and Development spending in excess of US $10 billion. ...
Breaking Biology News(10 mins):
(Date:9/1/2020)... ... September 01, 2020 , ... Slone Partners ... has announced the placement of Julianne Averill , CPA, as Chief Financial ... financial operations and implementing key business strategies to accelerate Alveo’s growth as the ...
(Date:8/15/2020)... ... August 13, 2020 , ... True Terpenes , ... of its Scientific Advisory Board (SAB) to research the medical potential of terpenes and ... enhanced when combined with terpenes. The board is focused on expanding the recently launched ...
(Date:8/12/2020)... ... August 11, 2020 , ... The FSHD Society announced ... Dystrophy Clinical Trial Research Network (FSHD CTRN), with consideration of follow-on ... consortium of academic research centers in the United States and Europe with expertise ...
(Date:8/12/2020)... ... August 12, 2020 , ... Inc. magazine today revealed ... in FDA compliance consulting has been named on its annual Inc. 5000 list, ... a unique look at the most successful companies within the American economy’s most ...
Breaking Biology Technology:
Cached News: